HURA
NASDAQ · Biotechnology

Tuhura Biosciences Inc

$1.81
-0.14 (-7.18%)
As of Mar 29, 10:51 PM ET ·
Financial Highlights (FY 2025)
Revenue
7.04M
Net Income
1.07M
Gross Margin
35.0%
Profit Margin
15.2%
Rev Growth
-2.7%
D/E Ratio
1.45
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 35.0% 35.0% 35.0%
Operating Margin 17.6% 21.5% 17.8%
Profit Margin 15.2% 19.8% 17.5%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 7.04M 7.06M 6.30M
Gross Profit 2.46M 2.47M 2.21M
Operating Income 1.24M 1.52M 1.12M
Net Income 1.07M 1.40M 1.10M
Gross Margin 35.0% 35.0% 35.0%
Operating Margin 17.6% 21.5% 17.8%
Profit Margin 15.2% 19.8% 17.5%
Rev Growth -2.7% +19.8% -1.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 20.88M 16.90M 20.52M
Total Equity 14.41M 15.53M 14.40M
D/E Ratio 1.45 1.09 1.43
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.93M 2.06M 1.69M
Free Cash Flow 1.16M 752.4K 1.14M